Keefe, Bruyette & Woods (KBW) has increased its price target for MetLife stock to $111 from $108 following the company's Q3 2026 earnings call. This adjustment reflects KBW's updated analysis of MetLife's financial performance and outlook, suggesting a slightly more positive view from the analyst firm.
Keefe, Bruyette & Woods (KBW) updated its price target for MetLife to $111 from $108 on November 10, 2026. This adjustment comes after MetLife's third-quarter 2026 earnings call on November 5, 2026, indicating that KBW's revised outlook is based on the company's recent financial performance and future prospects. While a price target increase is generally positive, this specific adjustment of $3 is relatively minor, suggesting a modest improvement in the analyst's valuation rather than a significant re-rating. For traders, this could provide a slight positive sentiment boost in the short term, but it's unlikely to be a major catalyst for sustained upward movement without other significant news. The long-term implications depend on whether MetLife's actual performance aligns with or exceeds this revised target.